Theres no one-size-fits-all for everyone
Gubras activities are focused on the early stages of drug development and are organised in two business areas CRO Services and Discovery & Partnerships (D&P)
At present, DSIP remains an experimental peptide with limited high-quality human data, and it has not been approved as a standard treatment for insomnia or psychiatric conditions
Att extrahera restvtska kan leda till felaktig dosering och kad risk fr biverkningar
A large within-group treatment effect (Cohens d = 1.46) was observed on the primary social anxiety measure, indicating substantial symptom improvement that exceeded effects reported in our previous RCTs on internet-delivered CBT for SAD, e.g., refs
By suppressing appetite, semaglutide helps reduce food intake and calorie consumption, paving the way for successful weight loss